Literature DB >> 9042106

Respective role of TNF receptors in the development of experimental cerebral malaria.

R Lucas1, J N Lou, P Juillard, M Moore, H Bluethmann, G E Grau.   

Abstract

The respective role of the two receptors of TNF in experimental cerebral malaria (CM) was investigated. During CM, a significant upregulation of TNF-receptor 2 (TNFR2), but not of TNFR1, was found in brain microvessels of susceptible, but not resistant mice. Mice genetically deficient for TNFR2 (Tnfr2null) were significantly protected from CM, while TNFR1-deficient (Tfnr1null) mice were as susceptible as wild-type mice. The protection of Tnfr2null mice could be explained by their absence of ICAM-1 upregulation and leukocyte sequestration, known to occur in brain microvessels of CM-susceptible animals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9042106     DOI: 10.1016/s0165-5728(96)00185-3

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  16 in total

1.  Assessing vascular permeability during experimental cerebral malaria by a radiolabeled monoclonal antibody technique.

Authors:  H C van der Heyde; P Bauer; G Sun; W L Chang; L Yin; J Fuseler; D N Granger
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 2.  TNF ligands and receptors--a matter of life and death.

Authors:  David J MacEwan
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

3.  Deficiency in tumor necrosis factor alpha activity does not impair early protective Th1 responses against blood-stage malaria.

Authors:  H Sam; Z Su; M M Stevenson
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice.

Authors:  N S Postma; R C Hermsen; D J Crommelin; W M Eling; J Zuidema
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

5.  Reactive changes of retinal microglia during fatal murine cerebral malaria: effects of dexamethasone and experimental permeabilization of the blood-brain barrier.

Authors:  I M Medana; T Chan-Ling; N H Hunt
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

6.  Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice.

Authors:  P F Piguet; C Da Laperrousaz; C Vesin; F Tacchini-Cottier; G Senaldi; G E Grau
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

7.  Platelet expression of tumour necrosis factor-alpha (TNF-alpha), TNF receptors and intercellular adhesion molecule-1 (ICAM-1) in patients with proliferative diabetic retinopathy.

Authors:  G A Limb; L Webster; H Soomro; S Janikoun; J Shilling
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

8.  Differential microRNA expression in experimental cerebral and noncerebral malaria.

Authors:  Fatima El-Assaad; Casper Hempel; Valéry Combes; Andrew J Mitchell; Helen J Ball; Jørgen A L Kurtzhals; Nicholas H Hunt; Jean-Marie Mathys; Georges E R Grau
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

9.  Role of CD40-CVD40L in mouse severe malaria.

Authors:  P F Piguet; C D Kan; C Vesin; A Rochat; Y Donati; C Barazzone
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

Review 10.  Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans.

Authors:  J Lou; R Lucas; G E Grau
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.